Ligand Pharmaceuticals Incorporated (LGND) Stock

Ligand Pharmaceuticals Incorporated (LGND) is a Healthcare stock trading at $273.81 (as of 2026-06-18), with a market capitalization of $4.65B and a trailing P/E of 30.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company developing or acquiring technologies used by pharmaceutical companies to discover and develop medicines. Its commercial products include therapies and formulations such as Kyprolis and Evomela for multiple myeloma, Veklury for COVID-19, and multiple other products including vaccines and specialty drug formulations used in areas like osteoporosis, postpartum depression, and leukemia.

Valuation — source: SEC EDGAR (first-party)
Price$273.81
Market Cap$4.65B
P/E Ratio30.2
EV / EBITDA35.5
Price / Book4.66
Price / Sales16.94
DCF Value (model)$42.83
DCF Upside vs Price-84.4%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$268.09M
Net Margin46.4%
Return on Equity15.4%
Current Ratio21.28
Revenue Growth (YoY)60.4%
EPS Growth (YoY)-3027.3%
FCF Growth (YoY)-48.6%
Financial Health — source: SEC EDGAR
Altman Z-Score7.44 (safe)
Valuation vs Sector & Industry
Stock P/E30.2
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector44.3%
vs Industry75.2%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock, Inc. ($591.35M)
Institutional Holders Tracked10
Congressional Trades (recent)4
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOTodd C. Davis
Employees68
CountryUS
IPO Date1992-11-18

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Mirum Pharmaceuticals, Inc. (MIRM)
  • Amneal Pharmaceuticals, Inc. (AMRX)
  • NewAmsterdam Pharma Company N.V. (NAMS)
  • Corcept Therapeutics Incorporated (CORT)
  • Arcutis Biotherapeutics, Inc. (ARQT)
  • CG Oncology, Inc. Common stock (CGON)
  • Kiniksa Pharmaceuticals, Ltd. (KNSA)
  • Dyne Therapeutics, Inc. (DYN)
LGND earnings history · LGND institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.